Healthcare - Medical - Diagnostics & Research - NASDAQ - US
$ 310.63
-7.23 %
$ 9.65 B
Market Cap
27.2
P/E
CASH FLOW STATEMENT
433 M
OPERATING CASH FLOW
-34.6 M
INVESTING CASH FLOW
-183 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Medpace Holdings, Inc.
| Net Income | 283 M |
| Depreciation & Amortization | 26.3 M |
| Capital Expenditures | -36.6 M |
| Stock-Based Compensation | 20.5 M |
| Change in Working Capital | 106 M |
| Others | 110 M |
| Free Cash Flow | 397 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||
| Net Income | 282.8 | 245.4 | 181.8 | 145.4 | 100.4 | 73.2 | 39.1 | 13.4 | (8.7) | (15.6) | 24.8 |
| Depreciation & Amortization | 26.3 | 22.3 | 21.1 | 19.5 | 23.2 | 38.8 | 46.5 | 58.1 | 69.5 | 68.1 | 30.5 |
| Deferred Income Tax | (25.1) | (23.0) | (37.1) | 0.5 | 10.1 | 3.9 | 3.2 | (9.0) | (12.7) | 0 | 6.0 |
| Stock Based Compensation | 20.5 | 21.4 | 14.5 | 13.8 | 20.7 | 6.5 | 4.5 | 9.8 | 22.3 | 12.8 | 2.0 |
| Other Operating Activities | 22.4 | 15.9 | 16.3 | 13.2 | 11.9 | (5.4) | (8.8) | 12.3 | 11.8 | 18.8 | 5.9 |
| Change in Working Capital | 106.5 | 106.1 | 66.7 | 66.3 | 35.6 | 39.6 | 12.9 | 7.1 | 1.9 | (8.9) | 28.9 |
| Cash From Operations | 433.4 | 388.1 | 263.3 | 258.7 | 201.9 | 156.6 | 97.4 | 91.7 | 84.1 | 75.2 | 98.1 |
| INVESTING CASH FLOW | |||||||||||
| Capital Expenditures | (36.6) | (36.9) | (28.3) | (31.3) | (17.9) | (16.0) | (12.3) | (13.5) | (6.5) | (5.3) | (4.6) |
| Other Items | 2.0 | (1.9) | (3.1) | 0.1 | (1.2) | (0.9) | 56 K | 0.1 | 33 K | (901.5) | 89 K |
| Cash From Investing Activities | (34.6) | (38.7) | (31.4) | (31.2) | (19.1) | (17.0) | (12.2) | (13.4) | (6.4) | (906.8) | (4.5) |
| FINANCING CASH FLOW | |||||||||||
| Common Stock Repurchased | (144.0) | (847.8) | (62.1) | (98.3) | 0 | 0 | (155.6) | 0 | 0 | 0 | 0 |
| Total Debt Repaid | (50.0) | 50.0 | 0 | 0 | (80.4) | (142.2) | 57.6 | (228.9) | (116.1) | 477.6 | (96.4) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 11.4 | 22.1 | 17.6 | 16.0 | 6.5 | 0.6 | 0.1 | (2.7) | (1.0) | 404.6 | (0.6) |
| Cash From Financing Activities | (182.6) | (775.8) | (44.5) | (82.3) | (73.9) | (141.6) | (97.8) | (58.0) | (116.5) | 882.2 | (95.9) |
| CHANGE IN CASH | |||||||||||
| Net Change In Cash | 217.2 | (433.0) | 183.5 | 145.8 | 108.6 | (3.2) | (10.9) | 19.7 | (39.4) | 51.0 | (2.0) |
| FREE CASH FLOW | |||||||||||
| Free Cash Flow | 396.7 | 351.2 | 235.1 | 227.3 | 184.0 | 140.6 | 85.1 | 78.2 | 77.7 | 69.9 | 93.6 |